"One drug has an orphan designation and the other drug is for a large indication where there is already an approved therapy"
This is all you could find? Of course these two are different. From a scientific perspective, DNDN's data package were much more persuasive than DORB. Add this to your list of differences.
Market Data 
Markets 
AI
